Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for VERTEPORFIN
- Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
- Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy
- Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment
- HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies
- Comparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN Regimen
- Clinical Study to Assess the Safety and Adequacy of Effectiveness of the SpectraCure P18 System
- Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study
- An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer
- Treatment of Primary Breast Cancer Using PDT
- Initial Versus Delayed PDT Combination With Conbercept in PCV
- Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies
- Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy
- Photodynamic Therapy for the Treatment of Vertebral Metastases
- Adjunctive Photodynamic Therapy + Aflibercept vs. Afilbercept Alone for PDA in NV AMD
- ICG-Guided Photodynamic Therapy for Treatment of Retinal Capillary Abnormalities: A Pilot Study
- Efficacy and Safety of Intravitreal Aflibercept Injection for Subacute Central Serous Chorioretinopathy
- Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia
- Efficacy and Safety of Ranibizumab 0.5 vs Verteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
- Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT)
- A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes
- Lucentis KAV Study
- Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy
- REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study
- Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
- Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular Degeneration
- Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular Degeneration
- Long-term Results After Intravitreal Bevacizumab Treatment Of Neovascular Age-related Macular Degeneration
- Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy
- Combination of Ranibizumab and Verteporfin Therapy in Neovascular Age-related Macular Degeneration
- Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization
- Efficacy of Ranibizumab in Combination With Photodynamic Therapy for Wet Age-Related Macular Degeneration
- Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy
- Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT)
- Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment
- Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy
- Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMD
- Photodynamic and Pharmacologic Treatment of CNV
- Retaane® in Age-Related Macular Degeneration
- Combined Photodynamic and Pulsed Dye Laser Treatment of Port Wine Stains
- Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis
- Ranibizumab and Reduced Fluence PDT for AMD
- CAPTAIN:Choroidal Neovascularization Assessment by Pattern Electroretinography
- Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)
- Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration
- TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration
- Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization
- Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)
- Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV
- Combination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMD
- Lucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular Degeneration
- The Avastin vs Visudyne for Neovascular AMD Study
- Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration
- Study of Ranibizumab Administered in Conjunction With Photodynamic Therapy With Verteporfin in Patients With Subfoveal Choroidal Neovascularization and Age-Related Macular Degeneration
- A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib
- Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC)
- Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)
- Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.
- Safety and Efficacy of Oral PTK787 in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration (AMD)
- Photodynamic Therapy in Occult-Only Lesions (POOL)
- Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD)
- Triamcinolone Acetonide Plus Laser Therapy to Treat Age-Related Macular Degeneration
- MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD)
- A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration
- Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)
- Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.
- Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy
- Photodynamic Therapy in Treating Patients With Stage III or Stage IV Melanoma
- Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors
Clinical trials list
click for details